Treating Barrett’s Esophagus: Time To End the Double Standard

The way we have approached most cancers in the practice of evidencebased medicine has been to remove the precursor lesion before the onset of cancer, thus preventing or minimizing the risk that cancer will develop. We do that for actinic keratosis, cervical dysplasia and colon polyps. We have not done it for Barrett’s esophagus, which is the immediate precursor to esophageal adenocarcinoma (EAC). The reason is that we did not have a safe or effective means of doing so—until now! . . . Click here to view the full article